Potassium Chloride Iv Suppliers & Bulk Manufacturers
Available Forms: Intravenous Infusion
Available Strengths: 2 mEq/mL, 10 mEq/5 mL, 20 mEq/10 mL
Reference Brands: Klor-Con®(US), Kalium Chlorid B. Braun®(EU)
Category: Critical Care
Potassium Chloride IV is available in Intravenous Infusion and strengths such as 2 mEq/mL, 10 mEq/5 mL, 20 mEq/10 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Potassium Chloride IV is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Potassium Chloride IV can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Potassium Chloride IV is a critical electrolyte replenishment solution used to treat or prevent hypokalemia in hospitalized patients. It is available in concentrated vials (2 mEq/mL, 10–20 mEq/10 mL) and premixed infusion bags (10–40 mEq in 100–1000 mL). Leading brands in the US include Klor-Con®, Baxter, and Hospira, while EU markets feature Kalium Chlorid by B. Braun and Fresenius. Due to its vital role in cardiac and neuromuscular function, Potassium Chloride IV is a high-priority hospital medicine. Pharma B2B platforms ensure consistent, large-scale procurement of Potassium Chloride IV solutions for ICUs, emergency departments, and critical care facilities.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Atovaquone/Proguanil
Strength:
250mg+100mg, 62.5mg+25mg
Form: Tablets
Reference Brands: Malarone (USA)
View DetailsArtesunate
Strength:
110 mg per vial
Form: Injection
Reference Brands: Generic formulations marketed under different names
View DetailsCabotegravir
Strength:
600 mg/3 mL, 30 mg
Form: Injection/ Tablet
Reference Brands: Apretude (USA), Vocabria (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers